Agustín Escobedo

401 total citations
16 papers, 320 citations indexed

About

Agustín Escobedo is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Agustín Escobedo has authored 16 papers receiving a total of 320 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 7 papers in Molecular Biology and 4 papers in Cancer Research. Recurrent topics in Agustín Escobedo's work include Cell death mechanisms and regulation (5 papers), Cancer-related Molecular Pathways (5 papers) and HER2/EGFR in Cancer Research (4 papers). Agustín Escobedo is often cited by papers focused on Cell death mechanisms and regulation (5 papers), Cancer-related Molecular Pathways (5 papers) and HER2/EGFR in Cancer Research (4 papers). Agustín Escobedo collaborates with scholars based in Spain, Italy and United States. Agustín Escobedo's co-authors include Àngels Fabra, Àngels Sierra, Abelardo Moreno, Teresa Cabrera, Federico Garrido, María Angustias Parejo Fernández, Xavier Castellsagué, António Garrido, Alfonso Herruzo and Belén Lloveras and has published in prestigious journals such as Cancer, International Journal of Cancer and European Journal of Cancer.

In The Last Decade

Agustín Escobedo

16 papers receiving 318 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Agustín Escobedo Spain	11	151	111	103	74	34	16	320
Kristiann M. Dougherty United States	8	130 0.9×	36 0.3×	179 1.7×	69 0.9×	39 1.1×	9	353
Rosa Lovis United States	7	74 0.5×	208 1.9×	114 1.1×	67 0.9×	16 0.5×	9	408
C M D'Urso Italy	6	123 0.8×	241 2.2×	103 1.0×	17 0.2×	15 0.4×	7	355
Alexander Henke Germany	7	83 0.5×	159 1.4×	130 1.3×	36 0.5×	27 0.8×	9	393
Caroline Imbert France	7	278 1.8×	268 2.4×	126 1.2×	39 0.5×	19 0.6×	19	468
Amirtharaj Francis India	12	110 0.7×	82 0.7×	179 1.7×	141 1.9×	20 0.6×	20	379
Peggy Richard-Fiardo France	8	193 1.3×	139 1.3×	103 1.0×	47 0.6×	44 1.3×	11	340
Yui Harada Japan	11	136 0.9×	135 1.2×	92 0.9×	34 0.5×	58 1.7×	26	324
William D. Walsh United States	9	63 0.4×	95 0.9×	106 1.0×	65 0.9×	30 0.9×	13	291
T Osaki Japan	6	133 0.9×	233 2.1×	240 2.3×	58 0.8×	66 1.9×	9	427

Countries citing papers authored by Agustín Escobedo

Since Specialization

Citations

This map shows the geographic impact of Agustín Escobedo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Agustín Escobedo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Agustín Escobedo more than expected).

Fields of papers citing papers by Agustín Escobedo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Agustín Escobedo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Agustín Escobedo. The network helps show where Agustín Escobedo may publish in the future.

Co-authorship network of co-authors of Agustín Escobedo

This figure shows the co-authorship network connecting the top 25 collaborators of Agustín Escobedo. A scholar is included among the top collaborators of Agustín Escobedo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Agustín Escobedo. Agustín Escobedo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

1.

Jordana‐Lluch, Elena, Montserrat Giménez, Agustín Escobedo, et al.. (2016). Molecular diagnosis of bloodstream infections in onco-haematology patients with PCR/ESI-MS technology. Journal of Infection. 74(2). 187–194. 17 indexed citations

2.

Falo, Catalina, Abelardo Moreno, Mar Varela, et al.. (2007). HER-2/neu status and response to CMF: retrospective study in a series of operable breast cancer treated with primary CMF chemotherapy. Journal of Cancer Research and Clinical Oncology. 133(7). 423–429. 18 indexed citations

3.

Arriola, Edurne, Abelardo Moreno, Mar Varela, et al.. (2006). Predictive value of HER-2 and Topoisomerase IIα in response to primary doxorubicin in breast cancer. European Journal of Cancer. 42(17). 2954–2960. 18 indexed citations

4.

Falo, Catalina, Abelardo Moreno, Enric Benito, et al.. (2005). Primary chemotherapy with cyclophosphamide, methotrexate, and 5‐fluorouracil in operable breast carcinoma. Cancer. 103(4). 657–663. 4 indexed citations

5.

Falo, Catalina, Abelardo Moreno, Belén Lloveras, et al.. (2003). Algorithm for the Diagnosis of HER-2/ neu Status in Breast-Infiltrating Carcinomas. American Journal of Clinical Oncology. 26(5). 465–470. 9 indexed citations

6.

Sabaté, Josep M., Antonio Gómez, Antonio Vidaller, et al.. (2002). Churg-Strauss syndrome involving the breast: a rare cause of eosinophilic mastitis. European Radiology. 12(3). 646–649. 17 indexed citations

7.

Moreno, Abelardo, et al.. (2002). Pathologic Changes Related to CMF Primary Chemotherapy in Breast Cancer. Breast Cancer Research and Treatment. 75(2). 119–125. 15 indexed citations

8.

Moreno, Abelardo, Albert Figueras, Belén Lloveras, et al.. (2001). Apoptosis in Ductal Carcinoma in Situ of the Breast. The Breast Journal. 7(4). 245–248. 11 indexed citations

9.

Sierra, Àngels, Xavier Castellsagué, Agustín Escobedo, et al.. (2000). Bcl-2 with loss of apoptosis allows accumulation of genetic alterations: A pathway to metastatic progression in human breast cancer. International Journal of Cancer. 89(2). 142–147. 34 indexed citations

10.

Sierra, Àngels, Xavier Castellsagué, Agustín Escobedo, et al.. (2000). Bcl-2 with loss of apoptosis allows accumulation of genetic alterations: A pathway to metastatic progression in human breast cancer. International Journal of Cancer. 89(2). 142–142. 3 indexed citations

11.

Sierra, Àngels, Xavier Castellsagué, Agustín Escobedo, et al.. (1999). Synergistic cooperation between c-Myc and Bcl-2 in lymph node progression of T1 human breast carcinomas. Breast Cancer Research and Treatment. 54(1). 39–45. 23 indexed citations

12.

Sierra, Àngels, et al.. (1998). Expression of death-related genes and their relationship to loss of apoptosis in T1 ductal breast carcinomas. International Journal of Cancer. 79(2). 103–110. 25 indexed citations

13.

Cabrera, Teresa, María Angustias Parejo Fernández, Àngels Sierra, et al.. (1996). High frequency of altered HLA class I phenotypes in invasive breast carcinomas. Human Immunology. 50(2). 127–134. 107 indexed citations

14.

Escobedo, Agustín, et al.. (1992). Treatment of pre-menopausal advanced breast cancer with goserelin—a long-acting luteinizing hormone releasing hormone agonist. Anti-Cancer Drugs. 3(1). 3–8. 6 indexed citations

15.

Brambilla, Cristina, et al.. (1991). Medical Castration with Zoladex: A Conservative Approach to Premenopausal Breast Cancer. Tumori Journal. 77(2). 145–150. 11 indexed citations

16.

Zambetti, Milvia, Luca Gianni, Francesco Di Re, et al.. (1990). Cisplatin and Cyclophosphamide in Advanced Ovarian Carcinoma. American Journal of Clinical Oncology. 13(3). 199–203. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact